Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Pathol Res Pract ; 204(2): 97-104, 2008.
Article in English | MEDLINE | ID: mdl-18079070

ABSTRACT

The aim of this study was to investigate the expression of p53, caspase-3, bcl-2, MIB-1, and PCNA to validate more objective methods to differentiate squamous cell carcinoma and keratoacanthoma, as well as to understand their pathogenesis with accuracy. A total of 52 cases of histopathologically diagnosed keratoacanthoma in the proliferative stage and 56 cases of well-differentiated squamous cell carcinoma were selected in this study. The expression was evaluated by means of immunohistochemistry. Bcl-2 immunoreactivity was weak or absent in the majority of cases, either in squamous cell carcinoma or in keratoacanthoma. PCNA-positive cells did not show differences between two lesions evaluated. On the other hand, MIB-1 was statistically significant (p<0.05) between squamous cell carcinomas and keratoacanthomas. Moreover, p53 and caspase-3 were overexpressed in squamous cell carcinomas. Together, these results suggest that the biological behavior of the well-differentiated squamous cell carcinomas of the skin may be associated with cellular proliferation and/or deregulation of cell death, indicated by increased expression of the MIB-1 and apoptotic proteins p53 and caspase-3, respectively.


Subject(s)
Apoptosis Regulatory Proteins/analysis , Apoptosis , Carcinoma, Squamous Cell/chemistry , Cell Cycle Proteins/analysis , Cell Proliferation , Keratoacanthoma/metabolism , Skin Neoplasms/chemistry , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/immunology , Carcinoma, Squamous Cell/pathology , Caspase 3/analysis , Cell Differentiation , Diagnosis, Differential , Humans , Immunohistochemistry , Keratoacanthoma/enzymology , Keratoacanthoma/immunology , Keratoacanthoma/pathology , Ki-67 Antigen/analysis , Proliferating Cell Nuclear Antigen/analysis , Proto-Oncogene Proteins c-bcl-2/analysis , Skin Neoplasms/enzymology , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Tumor Suppressor Protein p53/analysis
SELECTION OF CITATIONS
SEARCH DETAIL